Kidney Impairment

Title:

Description:

Kidney Impairment

Renal / Kidney Impairment


Help develop a new drug for Parkinson’s disease. We are seeking volunteers with severe renal (kidney) impairment to participate in a research study evaluating the pharmacokinetics* and safety of a single dose of investigational Tavapadon. A stipend of up to $2,825 is available for qualified study participants.

You may be eligible if you:

  • Are 18 to 80 years old
  • Have a BMI of 18 to 40
  • Have severe renal function: eGFR <30
  • Are not on dialysis
  • Are willing and able to complete a 7-night stay at our facility.
    • Our facility has:
      • Cable TV, Netflix, Hulu, ESPN & Disney+
      • Wi-Fi
      • Meals & snacks provided
      • Private room with memory foam mattress
      • Friendly staff
      • Outdoor patio and walking path

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive all study-related investigational drug, procedures, and medical exams at no cost. No health insurance is required to participate.

For more information call

(904) 730-0166

Or sign up below, and our office will call you!

* Pharmacokinetics (PK) studies the bodily absorption, distribution, metabolism, and excretion of drugs.




    This research study is enrolling at:


    Jacksonville Center for Clinical Research
    4085 University Blvd., South, Suite 1
    Jacksonville, FL 32216
    (904) 730-0166



    Learn More

    If you want us to contact you about our research studies call (904) 730-0166 or sign up below!

    Category
    Jacksonville (All Sites)
    Encore logo

    As a proven clinical research organization, we take every precaution to ensure the safety of and maximize the value for our research volunteers. Qualified doctors, nurses and study coordinators on staff provide support and care throughout the research trial. Participation is always voluntary. We appreciate the time and effort that research volunteers bring to this important process.

    Copyright 2023 ENCORE Research Group